ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,967 | -28.3% | 18,141 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $471,303 | -9.5% | 18,141 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $521,010 | -26.8% | 18,141 | -24.5% | 0.00% | -50.0% |
| Q4 2022 | $711,614 | +24.4% | 24,041 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $572,000 | -5.3% | 24,041 | -11.1% | 0.00% | -50.0% |
| Q2 2022 | $604,000 | -11.0% | 27,041 | -0.0% | 0.00% | +100.0% |
| Q1 2022 | $679,000 | -29.9% | 27,052 | +0.0% | 0.00% | -50.0% |
| Q4 2021 | $969,000 | -15.8% | 27,041 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,151,000 | -1.7% | 27,041 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,171,000 | -4.4% | 27,041 | -10.0% | 0.00% | -25.0% |
| Q1 2021 | $1,225,000 | -28.6% | 30,040 | -20.8% | 0.00% | -33.3% |
| Q4 2020 | $1,716,000 | +23.2% | 37,920 | -3.7% | 0.01% | +20.0% |
| Q3 2020 | $1,393,000 | -6.2% | 39,364 | +0.0% | 0.01% | -28.6% |
| Q2 2020 | $1,485,000 | +30.8% | 39,349 | +0.2% | 0.01% | +16.7% |
| Q1 2020 | $1,135,000 | -44.3% | 39,267 | +0.0% | 0.01% | -33.3% |
| Q4 2019 | $2,036,000 | -6.0% | 39,259 | -0.5% | 0.01% | -18.2% |
| Q3 2019 | $2,166,000 | +30.6% | 39,460 | -3.4% | 0.01% | +22.2% |
| Q2 2019 | $1,659,000 | +28.9% | 40,849 | -4.0% | 0.01% | +28.6% |
| Q1 2019 | $1,287,000 | -1.0% | 42,570 | +10.1% | 0.01% | -12.5% |
| Q4 2018 | $1,300,000 | -27.8% | 38,678 | -9.3% | 0.01% | -11.1% |
| Q3 2018 | $1,800,000 | +33.3% | 42,660 | +1.2% | 0.01% | +12.5% |
| Q2 2018 | $1,350,000 | -38.3% | 42,168 | -4.1% | 0.01% | -46.7% |
| Q1 2018 | $2,187,000 | -5.0% | 43,973 | +3.0% | 0.02% | 0.0% |
| Q4 2017 | $2,301,000 | -7.0% | 42,690 | +0.1% | 0.02% | -16.7% |
| Q3 2017 | $2,473,000 | +23.5% | 42,636 | +5.1% | 0.02% | +20.0% |
| Q2 2017 | $2,002,000 | +14.5% | 40,572 | +0.9% | 0.02% | +7.1% |
| Q1 2017 | $1,748,000 | +8.7% | 40,229 | +22.6% | 0.01% | 0.0% |
| Q4 2016 | $1,608,000 | +2.6% | 32,825 | +0.1% | 0.01% | -6.7% |
| Q3 2016 | $1,568,000 | -10.9% | 32,794 | 0.0% | 0.02% | -11.8% |
| Q2 2016 | $1,759,000 | +19.6% | 32,794 | -0.3% | 0.02% | +21.4% |
| Q1 2016 | $1,471,000 | +14.2% | 32,908 | -2.5% | 0.01% | +7.7% |
| Q4 2015 | $1,288,000 | +14.8% | 33,740 | -4.3% | 0.01% | -7.1% |
| Q3 2015 | $1,122,000 | -3.6% | 35,250 | 0.0% | 0.01% | +7.7% |
| Q2 2015 | $1,164,000 | -19.8% | 35,250 | 0.0% | 0.01% | -23.5% |
| Q1 2015 | $1,451,000 | +1.0% | 35,250 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $1,436,000 | +11.1% | 35,250 | 0.0% | 0.02% | 0.0% |
| Q3 2014 | $1,292,000 | -20.9% | 35,250 | 0.0% | 0.02% | -39.3% |
| Q2 2014 | $1,633,000 | +11.8% | 35,250 | -0.8% | 0.03% | +3.7% |
| Q1 2014 | $1,461,000 | +7.7% | 35,550 | 0.0% | 0.03% | 0.0% |
| Q4 2013 | $1,357,000 | +61.2% | 35,550 | +0.9% | 0.03% | +42.1% |
| Q3 2013 | $842,000 | +40.6% | 35,250 | 0.0% | 0.02% | +26.7% |
| Q2 2013 | $599,000 | – | 35,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |